Stock Markets
Redwoods Acquisition Corp. announces re-audited ANEW financials
Redwoods Acquisition Corp. (NASDAQ:RWOD), a special purpose acquisition company, disclosed today that ANEW MEDICAL, INC., with whom it has a pending business combination, has re-audited its financial statements for the year ended December 31, 2022. The re-audit was conducted by Yusufali & Associates, LLC, following the discovery that the company’s previous auditor, B.F. Borgers, CPA PC, is no longer permitted to practice before the SEC.
The re-audit was initiated to ensure the accuracy and reliability of ANEW’s financial reporting after the SEC barred B.F. Borgers from practicing. The re-audited financial statements, along with ANEW’s audited financials for the year ended December 31, 2023, and unaudited financials for the quarter ended March 31, 2024, have been filed with the SEC and are now publicly available.
Redwoods Acquisition Corp. and ANEW MEDICAL initially entered into a business combination agreement on May 30, 2023. The transaction is aimed at bringing ANEW, a company specializing in biological products, under the Redwoods umbrella as a wholly-owned subsidiary. The business combination is subject to approval by Redwoods’ shareholders and other customary closing conditions.
On February 14, 2024, the SEC declared effective the Registration Statement on Form S-4 filed in connection with the business combination, which included ANEW’s audited financials for the year ended December 31, 2022. However, the need for re-auditing arose after the SEC’s action against B.F. Borgers.
The announcement comes as Redwoods Acquisition Corp. continues to work towards completing the business combination with ANEW, which is anticipated to create a combined entity with enhanced growth prospects and operational synergies. Redwoods Acquisition Corp. is based in New York and is listed on The Nasdaq Stock Market LLC under the symbols RWODU for its units, RWOD for common stock, RWODW for warrants, and RWODR for rights.
This news is based on a press release statement and includes forward-looking statements subject to various risks and uncertainties. The completion of the proposed business combination is contingent upon several factors, including stockholder approval and the satisfaction of other closing conditions outlined in the definitive merger agreement.
In other recent news, Redwoods Acquisition Corp. has entered into a definitive agreement with Meteora Capital Partners and affiliates for a potential sale of equity securities. This transaction could result in Meteora Capital Partners and its affiliates acquiring up to 1,000,000 shares of Redwoods Acquisition Corp. The agreement, which is set to precede a planned merger with ANEW MEDICAL, INC., will adjust the number of shares purchased based on various market conditions and the seller’s discretion.
The shares in question represent the common stock of Redwoods Acquisition Corp. prior to the merger and will convert to the common stock of the post-merger entity. Redwoods Acquisition Corp. has also committed to a subscription agreement with the same parties, pledging to issue and sell up to 1,000,000 shares before a valuation date set within 30 days following the transaction.
Moreover, Redwoods Acquisition Corp. has agreed to file a registration statement with the SEC for the resale of all shares held by the seller, including any additional shares purchased. This filing is expected within 30 days of the trade date. These are among the recent developments in the company’s operations.
InvestingPro Insights
In light of Redwoods Acquisition Corp.’s (NASDAQ:RWOD) ongoing efforts to finalize the business combination with ANEW MEDICAL, INC., recent data from InvestingPro provides a snapshot of RWOD’s current financial health and market performance.
With a market capitalization of approximately $30.89 million and a high earnings multiple reflected by a P/E ratio of 59.62 for the last twelve months as of Q1 2024, investors are looking at a company that trades with significant price volatility. Despite being profitable over the last twelve months, RWOD’s short-term obligations currently exceed its liquid assets, which may raise concerns about the company’s financial flexibility in the near term.
InvestingPro Tips indicate that RWOD’s stock has experienced a notable decline over the past three months, with a 24.23% drop in price total return, and a 31.39% decrease over the last six months. Moreover, the stock does not pay a dividend, which could influence investor decisions, especially those seeking income-generating investments. It’s worth noting that for investors looking to make an informed decision, there are additional InvestingPro Tips available for RWOD at https://www.investing.com/pro/RWOD.
For those interested in a deeper dive into RWOD’s financials and market performance, using the promo code PRONEWS24 will provide an additional 10% off a yearly or biyearly Pro and Pro+ subscription to InvestingPro, where more comprehensive analysis and tips are available.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Stock Markets
SCWO Stock Hits 52-Week Low at $0.71 Amid Market Challenges
In a challenging market environment, shares of 374Water (SCWO) have touched a 52-week low, dipping to $0.71. The company, with a market capitalization of $104 million, maintains a strong liquidity position with a current ratio of 3.81 and more cash than debt on its balance sheet, according to InvestingPro data. The company, which specializes in water treatment solutions, has seen its stock price struggle significantly over the past year, reflecting a broader trend in the sector. Investors have been cautious, as evidenced by the stock’s 1-year change, which shows a substantial decline of 52.96%. InvestingPro analysis indicates the stock is currently in oversold territory, with 18 additional investment insights available to subscribers. This downturn highlights the volatility faced by environmental technology companies and raises concerns about future performance amidst uncertain market conditions. With a beta of -0.51, the stock typically moves opposite to market direction, potentially offering diversification benefits.
In other recent news, 374Water Inc. has secured approximately $12.2 million through a registered direct offering, involving the sale of common stock and warrants. The cleantech company expects the gross proceeds before fees and expenses to be around the $12.2 million mark, with D. Boral (OTC:) Capital LLC serving as the exclusive placement agent for the offering. The capital infusion is scheduled to be finalized by November 18, 2024, pending customary closing conditions.
In further developments, 374Water has initiated operations of its AirSCWO technology at the Iron Bridge Regional Water Reclamation Facility in Orlando. This marks a significant step in commercial biosolids processing, with the technology designed to efficiently process biosolids and PFAS contaminated wastes. The successful integration of the AirSCWO system into the Iron Bridge facility demonstrates the company’s capacity to destroy persistent organic pollutants, including PFAS.
The Florida Department of Environmental Protection supported the installation with a grant under the Bilateral Infrastructure Law emerging contaminant funding. Notably, CEO Chris Gannon highlighted the operational success in Orlando as crucial for showcasing the technology’s capacity to manage municipal, federal, and industrial organic waste streams at scale. The company anticipates additional commitments across the United States, including a deployment to Orange County Sanitation (CA) in 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Stock Markets
Global shares and dollar firm in muted pre-Christmas trade
By Alden Bentley, Samuel Indyk and Rae Wee
NEW YORK/LONDON (Reuters) -Wall Street topped off a global share rally in thin trade on Thursday as markets prepared for early Christmas Eve closes, while the dollar was buoyed by firmer Treasury yields and speculation that the Federal Reserve would slow its easing in 2025.
The was 0.47% higher in late morning trade, the rose 0.73% and the rose 0.99%.
U.S. stock trading wraps up at 1:00 p.m. EDT/1800 GMT, and the bond market closes at 2:00 p.m. Most financial centers around the world are closed on Wednesday for Christmas. The U.S. reopens on Thursday, while many financial centers have a second day off.
“Meagre news and data flow should keep the focus on a more hawkish Fed,” said Ipek Ozkardeskaya, senior analyst at Swissquote Bank.
MSCI’s gauge of stocks across the globe went up more than half a percent. The pan-European index rose 0.18%. 100 rose 0.19% and 40 rose 0.14%. German stocks were closed for the Christmas holiday.
In Asia, Chinese stocks rose after sources told Reuters that Beijing planned to issue a record amount of special treasury bonds next year as it ramps up fiscal stimulus to revive a faltering economy.
The blue-chip index and both ended 1.3% higher. Hong Kong’s advanced 1.1%.
The news came shortly after China’s finance ministry said authorities would ramp up fiscal support for consumption next year by raising pensions and medical insurance subsidies for residents, as well as expanding consumer goods trade-ins.
Still, investors remain cautious on the outlook for the world’s second-largest economy, particularly as it faces the threat of hefty tariffs from U.S. President-elect Donald Trump.
Elsewhere, MSCI’s broadest index of Asia-Pacific shares outside Japan rose 0.37%.
FED FOCUS
Investors are taking direction from last week’s 25 basis point Fed interest rate cut, its signals on the strength of the economy and its slow progress bringing inflation down to its 2% target. Markets are now pricing in about 35 basis points of easing for 2025, implying one quarter-point rate cut and around a 40% chance of a second.
U.S. Treasury yields pared gains after the Treasury saw solid demand for a $70 billion sale of five-year notes, but remained higher on the day. The two-year Treasury yield, which is sensitive to changes in Fed rate expectations, was up 0.9 bp at 4.359%, while the benchmark 10-year yield rose 2.6 bp to 4.625%, reaching a seven-month high at 4.629%. [US/]
“Like markets, the Fed will need to consider U.S. policies on tariffs and immigration in its inflation and growth outlook. We believe the subtle slowing in the U.S. labor market will still be the Fed’s paramount concern,” said analysts at Citi Wealth.
“While always uncertain, our base case expectation for a 3.75% policy rate is unchanged. It’s a far cry from the 1.7% U.S. policy rate average of the past 20 years.”
The Fed’s cut was the third one this cycle, taking the Fed funds rate to 4.25%-4.5%.
Ahead of Trump’s return to the White House in January, global central banks have urged caution over their rate paths due to uncertainty on how his planned tariffs, lower taxes and immigration curbs might affect policy.
Data on Monday showed U.S. consumer confidence unexpectedly weakened in December as the post-election euphoria fizzled and concerns about future business conditions emerged.
In currencies, the rose 0.14% hovering near a two-year high hit Monday, having climbed more than 2% in December so far.
The euro eased 0.15% to $1.0389, while the yen languished near last week’s five-month low, trading at 157.35 per dollar.
Japan’s Finance Minister Katsunobu Kato on Tuesday reiterated Tokyo’s discomfort with excessive foreign exchange moves and put speculators on notice that authorities are ready to act to stabilise a faltering yen.
rose 0.13% to $2,616.26 an ounce, having risen about 27% this year, heading for its biggest yearly gain since 2010.
rose 1.56% to $70.32 a barrel and rose to $73.73 per barrel, up 1.51% on the day. [O/R]
Stock Markets
Wall Street advances in short Christmas Eve session on megacap gains
By David French
(Reuters) -Wall Street’s main indexes all ended higher on Tuesday, with gains in megacap and growth stocks bolstering benchmarks in a truncated Christmas Eve session.
Both the and the scored four straight sessions of gains. For the Dow, the run follows its 10-session skid earlier this month, its longest losing streak since 1974.
The benchmarks closed higher on the first day of a historically strong period called the “Santa Claus rally.” The on average has gained 1.3% in the last five days of December and first two days of January, according to data from the Stock Trader’s Almanac going back to 1969.
With megacap stocks having outsized influence on markets, their performance is often a key driver of indexes. When coupled with reduced trading volumes and few other catalysts, as many investors take time off for the holidays, this is even more pronounced.
All the so-called Magnificent Seven megacap technology stocks climbed on Tuesday, led by Tesla (NASDAQ:).
The automaker’s rise helped push consumer discretionary shares higher, making them the top gaining sector in the S&P.
Elsewhere, chip manufacturers were also buoyant. Broadcom (NASDAQ:) and Nvidia (NASDAQ:) were up, while Arm Holdings (NASDAQ:) climbed a day after losses from losing a court case.
Growth names rose despite U.S. Treasury interest rates remaining elevated – the benchmark 10-year note yielded around 4.61% on Tuesday. Traditionally, higher debt costs crimp growth stocks.
However, the long-term themes around technology development, including advancements in artificial intelligence, overshadow any near-term moves in Treasuries, said Charlie Ripley, senior investment strategist for Allianz (ETR:) Investment Management.
“This reinforces that view that the sector is going to remain strong, and should be well into the new year,” he said.
According to preliminary data, the S&P 500 gained 64.93 points, or 1.09%, to end at 6,039.00 points, while the Nasdaq Composite gained 264.31 points, or 1.34%, to 20,029.19. The Dow Jones Industrial Average rose 366.75 points, or 0.85%, to 43,273.70.
Stock markets shut at 1:00 p.m. ET on Tuesday and will be closed for Christmas on Wednesday.
After a stellar run to record highs following the November election, which sparked hopes of pro-business policies under U.S. President-elect Donald Trump, Wall Street’s rally hit a bump this month as investors grappled with the prospect of higher interest rates in 2025.
The U.S. Federal Reserve eased borrowing costs for the third time this year last Wednesday, but signaled only two more 25-basis-point reductions next year, down from its September projection of four cuts, as policymakers weigh the possibility of Trump’s policies stoking inflation.
Allianz’s Ripley said the themes which had driven the market higher in the past two months remained intact, and actions by the Fed had not killed the rally.
“Heading into 2025, things are set up with good positioning,” he said, noting factors including economic outlook, consumption in the U.S. and the labor market.
Crypto-related stocks traded higher on Tuesday, including Microstrategy (NASDAQ:), Riot Platforms (NASDAQ:), and MARA Holdings, as the price of bitcoin advanced.
NeueHealth soared after the healthcare provider said New Enterprise Associates, its largest shareholder, and a group of existing investors will take the company private in a $1.3 billion deal.
- Forex2 years ago
Forex Today: the dollar is gaining strength amid gloomy sentiment at the start of the Fed’s week
- Forex2 years ago
How is the Australian dollar doing today?
- Forex2 years ago
Unbiased review of Pocket Option broker
- Forex2 years ago
Dollar to pound sterling exchange rate today: Pound plummeted to its lowest since 1985
- Cryptocurrency2 years ago
What happened in the crypto market – current events today
- World2 years ago
Why are modern video games an art form?
- Commodities2 years ago
Copper continues to fall in price on expectations of lower demand in China
- Forex2 years ago
The dollar is down again against major world currencies